As a transformational biopharmaceutical industry leader and growth strategist with more than 20 years of progressive experience, Amy Mahery develops strategies that boost multibillion-dollar brands, franchises, and companies on a global scale. She is a trusted C-suite member and board advisor with expertise spanning global pipeline development, marketing, franchise strategy, market access, and M and A. As Chief Commercial Officer at Roivant Sciences, Amy is establishing and leading the company’s commercial operations to drive the corporate strategy of expanding the business from a clinical developer to an end-to-end pharmaceutical company reaching diverse therapeutic areas and markets.
Amy earned her Bachelor of Science in neuroscience from Trinity College. She sat on the market access roundtable at Boston Consulting Group and was recognized by Profiles in Diversity Journal with the 2021 Women Worth Watching Award for leading the way to excellence in the workplace, the marketplace, and the world.
Amy earned her Bachelor of Science in neuroscience from Trinity College. She sat on the market access roundtable at Boston Consulting Group and was recognized by Profiles in Diversity Journal with the 2021 Women Worth Watching Award for leading the way to excellence in the workplace, the marketplace, and the world.
Activity